Zantac’s Developer Settles Lawsuits Claiming Cancer Link

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *